Irit DSc - Brainstorm Cell CoFounder Board
| GHDN Stock | EUR 2.69 0.00 0.00% |
Insider
Irit DSc is CoFounder Board of Brainstorm Cell Therapeutics
| Age | 63 |
| Phone | 201 488 0460 |
| Web | https://www.brainstorm-cell.com |
Brainstorm Cell Management Efficiency
The company has return on total asset (ROA) of (0.6831) % which means that it has lost $0.6831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.9343) %, meaning that it generated substantial loss on money invested by shareholders. Brainstorm Cell's management efficiency ratios could be used to measure how well Brainstorm Cell manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Rafael Casas | Coca Cola FEMSA SAB | 62 | |
| Alfonso Migoya | Coca Cola FEMSA SAB | 74 | |
| Karina Prez | Coca Cola FEMSA SAB | 55 | |
| Britta Seeger | Mercedes Benz Group AG | 54 | |
| Rick Carron | Superior Plus Corp | N/A | |
| Ludovic Helfgott | Novo Nordisk AS | 49 | |
| Washington Garcia | Coca Cola FEMSA SAB | N/A | |
| Ingrid Engstrom | SIVERS SEMICONDUCTORS AB | 59 | |
| Ola Kallenius | Mercedes Benz Group AG | 54 | |
| Robert Green | SIVERS SEMICONDUCTORS AB | 60 | |
| Allison Miller | NMI Holdings | N/A | |
| Sabine Kohleisen | Mercedes Benz Group AG | 59 | |
| Manfred Mueller | Identiv | 53 | |
| Norman Fitzgerald | NMI Holdings | 56 | |
| Renata Brungger | Mercedes Benz Group AG | 62 | |
| Tanya Pinoargote | Coca Cola FEMSA SAB | 53 | |
| Hubertus Troska | Mercedes Benz Group AG | 63 | |
| Monique Carter | Novo Nordisk AS | 50 | |
| John Murphy | Coca Cola FEMSA SAB | N/A | |
| Luis Gutierrez | Coca Cola FEMSA SAB | 55 | |
| Eduardo Pena | Coca Cola FEMSA SAB | 53 | |
Management Performance
| Return On Equity | -1.93 | |||
| Return On Asset | -0.68 |
Brainstorm Cell Ther Leadership Team
Elected by the shareholders, the Brainstorm Cell's board of directors comprises two types of representatives: Brainstorm Cell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brainstorm. The board's role is to monitor Brainstorm Cell's management team and ensure that shareholders' interests are well served. Brainstorm Cell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brainstorm Cell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yael Gothelf, VP Affairs | ||
| Irit DSc, CoFounder Board | ||
| Antal PearlLendner, VP Counsel | ||
| Daniel Offen, Chief Advisor | ||
| Stacy Lindborg, Exec Officer | ||
| Ralph Kern, COO and Chief Medical Officer | ||
| Chaim Lebovits, President CEO | ||
| PharmD MBA, Ex COO | ||
| Uri Yablonka, Executive Vice President Chief Business Officer, Director |
Brainstorm Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brainstorm Cell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.93 | |||
| Return On Asset | -0.68 | |||
| Current Valuation | 44.56 M | |||
| Shares Outstanding | 36.54 M | |||
| Shares Owned By Insiders | 22.70 % | |||
| Shares Owned By Institutions | 10.41 % | |||
| Price To Book | 36.30 X | |||
| EBITDA | (24.28 M) | |||
| Net Income | (24.46 M) | |||
| Cash And Equivalents | 6.22 M |
Currently Active Assets on Macroaxis
| 300825 | Iat Automobile Technology | |
| 600666 | Aurora Optoelectronics Co | |
| 000678 | Xiangyang Automobile Bearing | |
| 603818 | Qumei Furniture Group | |
| 002156 | TongFu Microelectronics Co |
Additional Information and Resources on Investing in Brainstorm Stock
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.